Vanderbilt-Shanghai Chronic Disease Research Training Program

范德比尔特-上海慢性病研究培训项目

• 批准号: 7696152
• 负责人: XIAO-Ou SHU
• 金额: $ 22.31万
• 依托单位: VANDERBILT UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-08-08 至 2014-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7696152
• 关键词: Adoption; Age; Award; Cardiovascular Diseases; Cause of Death; China; Chinese People; Chronic Disease; Cities; Collaborations; Communicable Diseases; Country; Developed Countries; Developing Countries; Diabetes Mellitus; Economic Development; Educational workshop; Ensure; Epidemic; Epidemiology; Future; Generations; Grant; Health; Institute of Medicine (U.S.); Institutes; Interdisciplinary Study; International; Leadership; Life Style; Malignant Neoplasms; Methodology; Modernization; Population; Prevention Research; Preventive Medicine; Public Health; Research; Research Personnel; Research Project Grants; Research Training; Scientist; Training; Training Programs; Universities; Work; Writing; design; disorder prevention; next generation; programs; public health relevance; skills; success; symposium

DESCRIPTION (provided by applicant): The rapid economic development, modernization and adoption of a Western lifestyle in China have been accompanied by the emergence of chronic disease epidemics. As a result, cardiovascular disease and cancer have now replaced infectious diseases as the leading causes of death in most cities in China. The burden of chronic disease is expected to continue increasing as the Chinese population ages. The Vanderbilt Institute for Medicine and Public Health and the Vanderbilt Institute for Global Health are partnering with the Shanghai Institutes of Preventive Medicine (SIPM), Fudan University, and the Shanghai Cancer Institute (SCI) to establish the Vanderbilt-Shanghai Chronic Disease Research Training Program (VU-Shanghai CDRTP). The specific aims of the CDRTP are: (1) to train a cadre of experts to conduct multi-disciplinary chronic disease research and build training capacity in China; (2). to train a new generation of scientists and future leaders in chronic diseases research in China; (3) to build research capacity in China and establish long-term collaborative relationships with Vanderbilt chronic disease researchers; (4) to ensure and document the long-term success of the training programs in China that are being facilitated and upgraded through this award; (5) to build national and international leadership in chronic disease prevention and control through existing and newly established networks. The training program includes scholar training (3 months at Vanderbilt), graduate training (1-2 years of didactic course work at Fudan University, a 3-month research practicum at SIPM or SCI, and 1 year of thesis research at Vanderbilt), two five-day, in-country workshops, and an international conference. The training will focus on advanced epidemiological and biostatistical methodology, design and execution of multidisciplinary research projects, and building expertise on cancer, cardiovascular disease and diabetes research, as well as grant writing skills. The VU-Shanghai CDRTP, building upon the strength of existing research and training programs and long-standing collaborations among the participating institutes, will have a significant and long-term impact on chronic disease research and prevention in China. PUBLIC HEALTH RELEVANCE: Chronic disease is emerging as the leading health burden in China. Vanderbilt will partner with public health leaders in Shanghai to train cadre of experts and next generation of researchers in chronic disease research, to build the research capacity and local training facilities. This program will have significant impact on chronic disease research and prevention in China, and possibly extend to other developing countries.

描述（由申请人提供）：中国西方生活方式的快速经济发展，现代化和采用伴随着慢性病流行病的出现。结果，心血管疾病和癌症现已取代了传染病，作为中国大多数城市的主要死亡原因。随着中国人口年龄的增长，慢性病的负担预计将继续增加。范德比尔特医学和公共卫生研究所和范德比尔特全球健康研究所正在与上海预防医学研究所（SIPM），福丹大学和上海癌症研究所（SCI）合作，建立范德比尔特 - - - ---------- CDRTP的具体目的是：（1）培训一群专家，以进行多学科的慢性病研究并在中国建立培训能力； （2）。在中国培训新一代科学家和未来的慢性疾病研究领导者； （3）在中国建立研究能力并与范德比尔特慢性疾病研究人员建立长期合作关系； （4）确保并记录中国培训计划的长期成功，这些计划正在通过该奖项促进和升级； （5）通过现有和新建立的网络在慢性疾病预防和控制方面建立国家和国际领导。该培训计划包括学者培训（范德比尔特的3个月），研究生培训（在Fudan University的1 - 2年教学课程工作，SIPM或SCI的3个月研究实践以及在Vanderbilt的1年论文研究），两个为期五天的，五日的国内工作室和国际会议。该培训将着重于高级流行病学和生物统计学方法，多学科研究项目的设计和执行以及建立癌症，心血管疾病和糖尿病研究的专业知识以及赠款写作技巧。 VU-Shanghai CDRTP基于现有研究和培训计划的实力以及参与机构之间的长期合作，将对中国的慢性病研究和预防产生重大的长期影响。公共卫生相关性：慢性病正在成为中国的领先健康负担。范德比尔特（Vanderbilt）将与上海的公共卫生领导人合作，培训专家干部和慢性病研究中的下一代研究人员，以建立研究能力和当地培训设施。该计划将对中国的慢性疾病研究和预防产生重大影响，并可能扩展到其他发展中国家。